Therapeutic agents for pancreatic cancer
a technology for pancreatic cancer and compositions, applied in the field of therapeutic compositions for pancreatic cancer, can solve the problems of rapid progress and poor prognosis, early recurrence after, and inability to achieve significant improvement in extended survival of pancreatic cancer patients, and achieve excellent therapeutic effect against pancreatic cancer. , the effect of reducing metastatic lesions of human pancreatic cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Effect of Combined Administration of Gemcitabine Hydrochloride and Tocilizumab on Pancreatic Cancer
[0160]A chemotherapy-naive patient having progressive / metastatic pancreatic cancer and showing CRP>=2.0 mg / dL (CRP: C-reactive protein that correlates with the intensity of inflammatory response) was treated with gemcitabine hydrochloride and a humanized IL-6 receptor antibody (tocilizumab).
[0161]A male at age 72 with no history of smoking having pancreatic body cancer of Stage IV as defined by the TNM classification of UICC1) had metastatic lesions in the liver, lymph nodes, ascites and peritoneum and had evident ascites as shown in FIG. 1. This case had a CRP of 3.28 mg / dL immediately before administration and also suffered from hyperlipidemia and chronic atrophic gastritis as complications. This patient was treated with gemcitabine hydrochloride and tocilizumab in combination. Gemcitabine hydrochloride was administered by intravenous drip injection at 1000 mg / m2 expressed as gemcita...
PUM
Property | Measurement | Unit |
---|---|---|
Therapeutic | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com